Sabra Health Care (SBRA) | Financial Analysis & Statements
Sabra Health Care REIT Inc. Mid-cap Real Estate
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
211.9M
Gross Profit
131.5M
62.05%
Operating Income
64.6M
30.48%
Net Income
27.1M
12.81%
EPS (Diluted)
$0.11
Balance Sheet Metrics
Total Assets
5.5B
Total Liabilities
2.7B
Shareholders Equity
2.8B
Debt to Equity
0.95
Cash Flow Metrics
Operating Cash Flow
79.8M
Free Cash Flow
87.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Sabra Health Care Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 774.6M | 703.2M | 647.5M | 624.8M | 569.5M |
| Cost of Goods Sold | 271.1M | 227.1M | 195.2M | 162.6M | 141.2M |
| Gross Profit | 503.5M | 476.1M | 452.3M | 462.2M | 428.3M |
| Gross Margin % | 65.0% | 67.7% | 69.8% | 74.0% | 75.2% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 53.7M | 50.1M | 47.5M | 39.6M | 34.7M |
| Other Operating Expenses | - | -571.0K | - | 141.0K | 3.9M |
| Total Operating Expenses | 53.7M | 49.5M | 47.5M | 39.7M | 38.6M |
| Operating Income | 263.9M | 256.5M | 221.5M | 234.7M | 210.7M |
| Operating Margin % | 34.1% | 36.5% | 34.2% | 37.6% | 37.0% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 112.5M | 115.3M | 113.0M | 105.5M | 98.6M |
| Other Non-Operating Income | 6.0M | -13.5M | -92.8M | -205.6M | -223.5M |
| Pre-tax Income | 157.3M | 127.7M | 15.8M | -76.4M | -111.4M |
| Income Tax | 1.8M | 1.0M | 2.0M | 1.2M | 1.8M |
| Effective Tax Rate % | 1.2% | 0.8% | 12.7% | 0.0% | 0.0% |
| Net Income | 155.5M | 126.7M | 13.8M | -77.6M | -113.3M |
| Net Margin % | 20.1% | 18.0% | 2.1% | -12.4% | -19.9% |
| Key Metrics | |||||
| EBITDA | 468.8M | 429.0M | 404.3M | 323.4M | 198.0M |
| EPS (Basic) | $0.64 | $0.54 | $0.06 | $-0.34 | $-0.52 |
| EPS (Diluted) | $0.64 | $0.54 | $0.06 | $-0.34 | $-0.52 |
| Basic Shares Outstanding | 241312309 | 233498736 | 231203391 | 230947895 | 219073027 |
| Diluted Shares Outstanding | 241312309 | 233498736 | 231203391 | 230947895 | 219073027 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Sabra Health Care Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 71.5M | 60.5M | 41.3M | 49.3M | 112.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 111.3M | 131.8M | 133.8M | 147.9M | 138.1M |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 189.4M | 198.1M | 543.3M | 562.2M | 596.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | - | - | - | - |
| Goodwill | 65.3M | 27.5M | 30.9M | 40.1M | 54.1M |
| Intangible Assets | 65.3M | 27.5M | 30.9M | 40.1M | 54.1M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 5.3B | 5.1B | 4.8B | 5.2B | 5.4B |
| Total Assets | 5.5B | 5.3B | 5.4B | 5.7B | 6.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | - | - | - | - | - |
| Short-term Debt | 217.6M | 106.6M | 94.4M | 197.0M | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 336.9M | 224.4M | 231.4M | 339.2M | 143.0M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.3B | 2.3B | 2.4B | 2.4B | 2.4B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | 32.5M | 42.2M | 49.7M |
| Total Non-Current Liabilities | 2.3B | 2.3B | 2.4B | 2.4B | 2.4B |
| Total Liabilities | 2.7B | 2.6B | 2.6B | 2.7B | 2.6B |
| Equity | |||||
| Common Stock | 2.5M | 2.4M | 2.3M | 2.3M | 2.3M |
| Retained Earnings | -2.0B | -1.9B | -1.7B | -1.5B | -1.1B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.8B | 2.7B | 2.8B | 3.1B | 3.4B |
| Key Metrics | |||||
| Total Debt | 2.6B | 2.4B | 2.4B | 2.5B | 2.4B |
| Working Capital | -147.5M | -26.4M | 311.9M | 222.9M | 453.0M |
Balance Sheet Composition
Sabra Health Care Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 155.5M | 126.7M | 13.8M | -77.6M | -113.3M |
| Depreciation & Amortization | 187.0M | 169.6M | 183.1M | 187.8M | 179.0M |
| Stock-Based Compensation | 11.4M | 9.0M | 7.9M | 7.5M | 7.9M |
| Working Capital Changes | -11.4M | -15.5M | -11.1M | -6.4M | 22.7M |
| Operating Cash Flow | 332.2M | 296.0M | 193.2M | 124.3M | 128.6M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | -1.2M | -1.3M | -5.2M | -142.9M | 0 |
| Investment Purchases | -9.0K | -2.8M | -11.0M | -8.0M | -9.1M |
| Investment Sales | 7.0M | 5.9M | 5.5M | 5.4M | 1.3M |
| Investing Cash Flow | 21.1M | -13.9M | -7.1M | -164.9M | -294.8M |
| Financing Activities | |||||
| Share Repurchases | - | - | -2.7M | -4.8M | - |
| Dividends Paid | -289.5M | -280.2M | -277.4M | -277.2M | -262.9M |
| Debt Issuance | 609.8M | 14.6M | 12.2M | 204.0M | 791.5M |
| Debt Repayment | -502.1M | -2.0M | -106.3M | -81.3M | -767.7M |
| Financing Cash Flow | 40.8M | -181.6M | -410.3M | 42.3M | 30.1M |
| Free Cash Flow | 348.6M | 310.5M | 300.6M | 315.7M | 356.4M |
| Net Change in Cash | 394.0M | 100.6M | -224.3M | 1.8M | -136.1M |
Cash Flow Trend
Sabra Health Care Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
31.39
Forward P/E
25.59
Price to Book
1.79
Price to Sales
6.53
PEG Ratio
-0.70
Profitability Ratios
Profit Margin
20.06%
Operating Margin
23.70%
Return on Equity
5.59%
Return on Assets
3.07%
Financial Health
Current Ratio
1.80
Debt to Equity
89.86
Beta
0.65
Per Share Data
EPS (TTM)
$0.64
Book Value per Share
$11.21
Revenue per Share
$3.22
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SBRA | 5.0B | 31.39 | 1.79 | 5.59% | 20.06% | 89.86 |
| Welltower | 147.1B | 146.65 | 3.44 | 2.54% | 8.64% | 49.49 |
| Ventas | 39.8B | 153.57 | 3.14 | 2.17% | 4.32% | 102.00 |
| American Healthcare | 9.6B | 119.29 | 2.80 | 2.50% | 3.09% | 50.20 |
| CareTrust REIT | 8.5B | 23.76 | 2.06 | 9.17% | 67.28% | 71.95 |
| Healthcare Realty | 6.6B | 39.90 | 1.39 | -5.00% | -20.85% | 88.77 |
Financial data is updated regularly. All figures are in the company's reporting currency.






